Enicuela, Patricia .
HRN: 25-85-85 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/28/2024
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
09/28/2024
10/04/2024
IV
750
Od
Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes